ArticleFrontiers in cardiovascular medicine2026

Pretreatment cardiometabolic risk in newly diagnosed breast cancer: a molecular subtype analysis.

Zechang Xin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.